NO20006381D0 - Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents - Google Patents

Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents

Info

Publication number: NO20006381D0
Authority: NO; Norway
Prior art keywords: serm; selective; growth hormone; estrogen receptor; receptor modulators
Prior art date: 1998-06-16

Application number

NO20006381A

Other languages

Norwegian (no)

Other versions

NO20006381L (en

Inventor

Hua Zhu Ke

Mei Li

Lydia Codetta Pan

David Duane Thompson

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

2000-12-14

Publication date

2000-12-14

2000-12-14 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-12-14 Publication of NO20006381L publication Critical patent/NO20006381L/en

2000-12-14 Publication of NO20006381D0 publication Critical patent/NO20006381D0/en

Links

102000018997 Growth Hormone Human genes 0.000 title 1
108010051696 Growth Hormone Proteins 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1
239000002834 estrogen receptor modulator Substances 0.000 title 1
239000000122 growth hormone Substances 0.000 title 1
230000028327 secretion Effects 0.000 title 1
239000000333 selective estrogen receptor modulator Substances 0.000 title 1
229940095743 selective estrogen receptor modulator Drugs 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20006381A 1998-06-16 2000-12-14 Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents NO20006381D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8942498P	1998-06-16	1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en)	1998-06-16	1999-05-03	Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number	Publication Date
NO20006381L NO20006381L (en)	2000-12-14
NO20006381D0 true NO20006381D0 (en)	2000-12-14

Family

ID=22217565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20006381A NO20006381D0 (en)	1998-06-16	2000-12-14	Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents

Country Status (29)

Country	Link
EP (1)	EP1085867A1 (en)
JP (1)	JP2002518328A (en)
KR (1)	KR20010052817A (en)
CN (1)	CN1305378A (en)
AP (1)	AP9901581A0 (en)
AR (1)	AR018868A1 (en)
AU (1)	AU3342099A (en)
BG (1)	BG105128A (en)
BR (1)	BR9911357A (en)
CA (1)	CA2335112A1 (en)
CO (1)	CO5070586A1 (en)
EA (1)	EA200001189A1 (en)
GT (1)	GT199900083A (en)
HR (1)	HRP20000857A2 (en)
HU (1)	HUP0102395A2 (en)
ID (1)	ID26726A (en)
IL (1)	IL139587A0 (en)
IS (1)	IS5727A (en)
MA (1)	MA26648A1 (en)
NO (1)	NO20006381D0 (en)
OA (1)	OA11569A (en)
PA (1)	PA8472101A1 (en)
PE (1)	PE20000633A1 (en)
PL (1)	PL345064A1 (en)
SK (1)	SK18902000A3 (en)
TN (1)	TNSN99118A1 (en)
UY (1)	UY25557A1 (en)
WO (1)	WO1999065488A1 (en)
ZA (1)	ZA993973B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1004306A3 (en) *	1998-08-06	2000-06-07	Pfizer Products Inc.	Estrogen agonists/antagonists
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
AP2001002264A0 (en)	2000-08-30	2001-09-30	Pfizer Prod Inc	Sustained release formulations for growth hormone secretagogues.
US7524866B2 (en)	2001-11-29	2009-04-28	Gtx, Inc.	Prevention and treatment of androgen—deprivation induced osteoporosis
MXPA04005112A (en) *	2001-11-29	2005-04-29	Gtx Inc	Prevention and treatment of androgen-deprivation induced osteoporosis.
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
KR20090107088A (en)	2007-02-09	2009-10-12	트랜자임 파르마 인크	Macrocyclic ghrelin receptor modulators and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA51676C2 (en) *	1995-11-02	2002-12-16	Пфайзер Інк.	(-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (en) *	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS

1999
- 1999-05-03 JP JP2000554368A patent/JP2002518328A/en active Pending
- 1999-05-03 PL PL99345064A patent/PL345064A1/en unknown
- 1999-05-03 KR KR1020007014140A patent/KR20010052817A/en not_active Ceased
- 1999-05-03 IL IL13958799A patent/IL139587A0/en unknown
- 1999-05-03 SK SK1890-2000A patent/SK18902000A3/en unknown
- 1999-05-03 BR BR9911357-0A patent/BR9911357A/en not_active Application Discontinuation
- 1999-05-03 HU HU0102395A patent/HUP0102395A2/en unknown
- 1999-05-03 CA CA002335112A patent/CA2335112A1/en not_active Abandoned
- 1999-05-03 WO PCT/IB1999/000796 patent/WO1999065488A1/en not_active Ceased
- 1999-05-03 EP EP99914723A patent/EP1085867A1/en not_active Withdrawn
- 1999-05-03 ID IDW20002604A patent/ID26726A/en unknown
- 1999-05-03 OA OA1200000346A patent/OA11569A/en unknown
- 1999-05-03 AU AU33420/99A patent/AU3342099A/en not_active Abandoned
- 1999-05-03 HR HR20000857A patent/HRP20000857A2/en not_active Application Discontinuation
- 1999-05-03 CN CN99807381A patent/CN1305378A/en active Pending
- 1999-05-03 EA EA200001189A patent/EA200001189A1/en unknown
- 1999-05-07 PA PA19998472101A patent/PA8472101A1/en unknown
- 1999-06-10 AP APAP/P/1999/001581A patent/AP9901581A0/en unknown
- 1999-06-11 PE PE1999000522A patent/PE20000633A1/en not_active Application Discontinuation
- 1999-06-11 UY UY25557A patent/UY25557A1/en not_active Application Discontinuation
- 1999-06-14 GT GT199900083A patent/GT199900083A/en unknown
- 1999-06-15 TN TNTNSN99118A patent/TNSN99118A1/en unknown
- 1999-06-15 ZA ZA9903973A patent/ZA993973B/en unknown
- 1999-06-15 AR ARP990102847A patent/AR018868A1/en not_active Application Discontinuation
- 1999-06-15 MA MA25622A patent/MA26648A1/en unknown
- 1999-06-16 CO CO99037624A patent/CO5070586A1/en unknown
2000
- 2000-11-24 IS IS5727A patent/IS5727A/en unknown
- 2000-12-14 NO NO20006381A patent/NO20006381D0/en not_active Application Discontinuation
2001
- 2001-01-08 BG BG105128A patent/BG105128A/en unknown

Also Published As

Publication number	Publication date
PA8472101A1 (en)	2000-09-29
IS5727A (en)	2000-11-24
GT199900083A (en)	2000-12-05
CN1305378A (en)	2001-07-25
WO1999065488A1 (en)	1999-12-23
HRP20000857A2 (en)	2001-10-31
AP9901581A0 (en)	1999-06-30
ZA993973B (en)	2000-12-15
HUP0102395A2 (en)	2001-11-28
UY25557A1 (en)	2001-01-31
IL139587A0 (en)	2002-02-10
NO20006381L (en)	2000-12-14
SK18902000A3 (en)	2001-12-03
AU3342099A (en)	2000-01-05
AR018868A1 (en)	2001-12-12
EP1085867A1 (en)	2001-03-28
BR9911357A (en)	2001-03-13
PE20000633A1 (en)	2000-07-26
EA200001189A1 (en)	2001-06-25
MA26648A1 (en)	2004-12-20
OA11569A (en)	2004-07-01
PL345064A1 (en)	2001-11-19
JP2002518328A (en)	2002-06-25
TNSN99118A1 (en)	2005-11-10
BG105128A (en)	2001-11-30
CO5070586A1 (en)	2001-08-28
ID26726A (en)	2001-02-01
CA2335112A1 (en)	1999-12-23
KR20010052817A (en)	2001-06-25

Similar Documents

Publication	Publication Date	Title
NO20025143D0 (en)	2002-10-25	Modulators of receptors for parathyroid hormone and parathyroid hormone-linked protein
NO20020912L (en)	2002-04-29	Bicyclic androgen and progesterone receptor modulator compounds and methods
NO20024478L (en)	2002-09-19	Hormone replacement therapy using combination of conjugated estrogens and medroxyprogesterone acetate
NO981426D0 (en)	1998-03-30	Method and apparatus for primary-well cementing
IL139915A0 (en)	2002-02-10	Improved methods and apparatus for multi-photon photo-activation of therapeutic agents
EE200100053A (en)	2002-06-17	Use of biogenic estrogen sulfamates for hormone replacement therapy
DE69838202D1 (en)	2007-09-20	End point sensation and apparatus
DK1089719T3 (en)	2002-08-05	Transdermal therapeutic system containing hormones and crystallization inhibitors
NO20006381D0 (en)	2000-12-14	Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents
IL148421A0 (en)	2002-09-12	Pharmaceutical compositions and methods of using secreted frizzled related protein
NO991593L (en)	1999-06-07	Hormone preparation consisting of a ° estrogen compound and a progesterone compound
DK0994706T3 (en)	2006-03-06	Preparations for oral administration of taxanes and their use
NO20006313D0 (en)	2000-12-12	Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
NO20006312D0 (en)	2000-12-12	Therapeutic mixtures of selective estrogen receptor modulators (SERM) and growth hormone secretion stimulant (GHS) for the treatment of musculoskeletal fragility
EE05172B1 (en)	2009-06-15	Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological diseases
HU9701364D0 (en)	1997-09-29	Procedure for making (r) and (s) isomers of alfa-metil-2-[3-(trifluor-metil)-fenil]-etil-amin
NO20021947L (en)	2002-06-14	Bio-borne matrices, method of preparation and use thereof
GR3033590T3 (en)	2000-09-29	Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
NO20032969D0 (en)	2003-06-27	Method of Screening for Progesterone Receptor Isoform-Specific Ligands and for Tissue Selective Progesterone Receptor Ligands
LT97021A (en)	1998-02-25	Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
SI1265616T1 (en)	2006-08-31	Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
AU5084798A (en)	1999-05-10	Curing of orthopedic casting material and device and method for using same
AU4562100A (en)	2000-12-05	Method for passing a mixture of liquid through human and/or animal organs or extremities
SI0935469T1 (en)	2003-06-30	Use of growth hormone

Legal Events

Date	Code	Title	Description
2003-01-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application